Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
123,850,680
-
Total 13F shares
-
73,788,961
-
Share change
-
-2,190,988
-
Total reported value
-
$4,709,899,224
-
Put/Call ratio
-
251%
-
Price per share
-
$63.83
-
Number of holders
-
225
-
Value change
-
-$154,901,989
-
Number of buys
-
142
-
Number of sells
-
92
Institutional Holders of Guardant Health, Inc. - Common Stock (GH) as of Q3 2019
As of 30 Sep 2019,
Guardant Health, Inc. - Common Stock (GH) was held by
225 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
73,788,961 shares.
The largest 10 holders included
SB INVESTMENT ADVISERS (UK) LTD, MORGAN STANLEY, VK Services, LLC, JENNISON ASSOCIATES LLC, VANGUARD GROUP INC, SC US (TTGP), LTD., VIKING GLOBAL INVESTORS LP, PRICE T ROWE ASSOCIATES INC /MD/, JPMORGAN CHASE & CO, and BlackRock Inc..
This page lists
226
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.